Journal Browser Advanced Search Help
Journal Browser Advanced search HELP
Chonnam Med J. 2017 May;53(2):110-117. English. Review. https://doi.org/10.4068/cmj.2017.53.2.110
Cho HJ , Kim DW , Kim GS , Jeong IS .
Department of Pediatrics, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea.
Department of Thoracic and Cardiovascular Surgery, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea. isjeong1201@gmail.com
Extracorporeal Life Support Organization, Asia-Pacific Chapter, Ann Arbor, MI, USA.
Abstract

Extracorporeal membrane oxygenation (ECMO) is a salvage therapy for critically ill patients. Although ECMO is becoming more common, hemorrhagic and thromboembolic complications remain the major causes of death in patients undergoing ECMO treatments. These complications commence upon blood contact with artificial surfaces of the circuit, blood pump, and oxygenator system. Therefore, anticoagulation therapy is required in most cases to prevent these problems. Anticoagulation is more complicated in pediatric patients than in adults, and the foreign surface of ECMO only increases the complexity of systemic anticoagulation. In this review, we discuss the pathophysiology of coagulation, anticoagulants, and monitoring tools in pediatric patients receiving ECMO.

Copyright © 2019. Korean Association of Medical Journal Editors.